{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.16","upperLimit":"0.29","value":"0.18"},{"groupId":"OG001","lowerLimit":"0.42","upperLimit":"1.16","value":"0.60"},{"groupId":"OG002","lowerLimit":"0.62","upperLimit":"1.49","value":"0.90"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"114"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"107"}],"units":"Participants"}],"description":"The time to progression is defined as the time from registration to the time of progression. The distribution of time to progression was estimated using the method of Kaplan-Meier.","dispersionType":"95% Confidence Interval","groups":[{"description":"Study 1.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG000","title":"Relapsed Aggressive Non-Hodgkin Lymphoma"},{"description":"Study 2.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG001","title":"Relapsed Indolent Non-Hodgkin Lymphoma"},{"description":"Study 3. Includes Hodgkin's lymphomas.\n\nEverolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.\n\nEverolimus : Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable toxicity, refusal, or alternative therapy at any time.","id":"OG002","title":"Uncommon Lymphomas"}],"paramType":"MEDIAN","populationDescription":"276 out of 277 were analyzed for response. One patient was excluded because of patient refusal before starting treatment.","reportingStatus":"POSTED","timeFrame":"5 years","title":"Time to Progression","type":"SECONDARY","unitOfMeasure":"years"}